These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 9755298)

  • 21. Increasing ciprofloxacin resistance among prevalent urinary tract bacterial isolates in Bangladesh.
    Iqbal J; Rahman M; Kabir MS; Rahman M
    Jpn J Med Sci Biol; 1997 Dec; 50(6):241-50. PubMed ID: 9789787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibiotic resistance of urinary tract pathogens and evaluation of empirical treatment in Turkish children with urinary tract infections.
    Yüksel S; Oztürk B; Kavaz A; Ozçakar ZB; Acar B; Güriz H; Aysev D; Ekim M; Yalçinkaya F
    Int J Antimicrob Agents; 2006 Nov; 28(5):413-6. PubMed ID: 17000085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sex- and age-specific trends in antibiotic resistance patterns of Escherichia coli urinary isolates from outpatients.
    McGregor JC; Elman MR; Bearden DT; Smith DH
    BMC Fam Pract; 2013 Feb; 14():25. PubMed ID: 23433241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the minimum inhibitory, mutant prevention and minimum bactericidal concentrations of ciprofloxacin, levofloxacin and garenoxacin against enteric Gram-negative urinary tract infection pathogens.
    Hansen GT; Blondeau JM
    J Chemother; 2005 Oct; 17(5):484-92. PubMed ID: 16323436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibiotic Resistance among Urinary Isolates from Female Outpatients in the United States in 2003 and 2012.
    Sanchez GV; Babiker A; Master RN; Luu T; Mathur A; Bordon J
    Antimicrob Agents Chemother; 2016 May; 60(5):2680-3. PubMed ID: 26883714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antimicrobial resistance of gram-negative bacteria: A six-year longitudinal study in a hospital in Saudi Arabia.
    Al-Tawfiq JA; Rabaan AA; Saunar JV; Bazzi AM
    J Infect Public Health; 2020 May; 13(5):737-745. PubMed ID: 32008927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trimethoprim in vitro antibacterial activity is not increased by adding sulfamethoxazole for pediatric Escherichia coli urinary tract infection.
    Nguyen HT; Hurwitz RS; Defoor WR; Minevich E; McAdam AJ; Mortensen JE; Novak-Weekley SM; Minnillo BJ; Elder JS
    J Urol; 2010 Jul; 184(1):305-10. PubMed ID: 20488468
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antibiotic resistance of E coli isolated from healthy persons].
    Tvede M; Høiby N; Larsen LA; Raben A; Astrup AV
    Ugeskr Laeger; 2001 Sep; 163(36):4868-71. PubMed ID: 11571862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Five-year survey of changing patterns of susceptibility of bacterial uropathogens to trimethoprim-sulfamethoxazole and other antimicrobial agents.
    Alon U; Davidai G; Berant M; Merzbach D
    Antimicrob Agents Chemother; 1987 Jan; 31(1):126-8. PubMed ID: 3551824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro activities of quinolones, beta-lactams, tobramycin, and trimethoprim-sulfamethoxazole against nonfermentative gram-negative bacilli.
    Fass RJ; Barnishan J; Solomon MC; Ayers LW
    Antimicrob Agents Chemother; 1996 Jun; 40(6):1412-8. PubMed ID: 8726011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative potency of mecillinam and other beta-lactam antibiotics against Escherichia coli strains producing different beta-lactamases.
    Sougakoff W; Jarlier V
    J Antimicrob Chemother; 2000 Sep; 46 Suppl 1():9-14; discussion 63-5. PubMed ID: 11051618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro and in vivo antibacterial activity of nitrofurantoin against clinical isolates of E. coli in Japan and evaluation of biological cost of nitrofurantoin resistant strains using a mouse urinary tract infection model.
    Nakagawa S; Kurimoto Y; Ezumi M; Nakatani K; Mizunaga S; Yamagishi Y; Mikamo H
    J Infect Chemother; 2021 Feb; 27(2):250-255. PubMed ID: 33060044
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Why not performing susceptibility test for trimethoprim-sulphamethoxazole?
    Hagiya H
    J Chemother; 2015 Feb; 27(2):124-5. PubMed ID: 25248022
    [No Abstract]   [Full Text] [Related]  

  • 34. Widespread distribution of urinary tract infections caused by a multidrug-resistant Escherichia coli clonal group.
    Manges AR; Johnson JR; Foxman B; O'Bryan TT; Fullerton KE; Riley LW
    N Engl J Med; 2001 Oct; 345(14):1007-13. PubMed ID: 11586952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibiotic resistance of bacterial strains isolated from patients with community-acquired urinary tract infections: an exploratory study in Palestine.
    Abu-Taha AS; Sweileh WM
    Curr Clin Pharmacol; 2011 Nov; 6(4):304-7. PubMed ID: 22082328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro activity of aminopenicillins combined with sulbactam, clavulanic acid, or amdinocillin against bacteria isolated from patients with complicated urinary tract infections.
    Naber KG; Wittenberger R
    Rev Infect Dis; 1986; 8 Suppl 5():S604-8. PubMed ID: 3026011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microbiology of urinary tract infections in Gaborone, Botswana.
    Renuart AJ; Goldfarb DM; Mokomane M; Tawanana EO; Narasimhamurthy M; Steenhoff AP; Silverman JA
    PLoS One; 2013; 8(3):e57776. PubMed ID: 23469239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activity of mecillinam against Escherichia coli resistant to third-generation cephalosporins.
    Wootton M; Walsh TR; Macfarlane L; Howe RA
    J Antimicrob Chemother; 2010 Jan; 65(1):79-81. PubMed ID: 19915068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibiotic resistance in outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA).
    Zhanel GG; Hisanaga TL; Laing NM; DeCorby MR; Nichol KA; Palatnik LP; Johnson J; Noreddin A; Harding GK; Nicolle LE; Hoban DJ;
    Int J Antimicrob Agents; 2005 Nov; 26(5):380-8. PubMed ID: 16243229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimicrobials commonly used for urinary tract infection: sulfonamides, trimethoprim-sulfamethoxazole, nitrofurantoin, nalidixic acid.
    Keys TF
    Mayo Clin Proc; 1977 Nov; 52(11):680-2. PubMed ID: 926843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.